Oxford Biomedica PLC
OXB | IL
Overview
Corporate Details
- ISIN(s):
- GB00BDFBVT43
- LEI:
- 213800S1GVQNXQ15K851
- Country:
- United Kingdom
- Address:
- WINDRUSH COURT, OX4 6LT OXFORD
- Website:
- https://www.oxb.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Oxford Biomedica PLC (OXB) is a global, innovation-led contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. As a pioneer with over 30 years of experience, the company provides end-to-end services for the development and GMP manufacturing of viral vectors, including lentivirus, adeno-associated virus (AAV), and adenovirus. OXB supports pharmaceutical and biotechnology clients, from early-stage development to commercialization, through its global network of facilities in the UK, US, and France. The company leverages proprietary technology platforms, such as its commercially approved LentiVector™ and inAAVate™ systems, to enable the delivery of life-changing therapies.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Oxford Biomedica PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-15 14:45 |
Director's Dealing
PDMR Dealings
|
English | 18.8 KB | |
| 2025-08-15 08:05 |
Share Issue/Capital Change
Results of Placing
|
English | 43.5 KB | |
| 2025-08-14 18:02 |
Share Issue/Capital Change
Proposed Placing of New Ordinary Shares
|
English | 168.6 KB | |
| 2025-08-01 08:00 |
Capital/Financing Update
OXB Secures New Loan Facility with Oaktree
|
English | 16.3 KB | |
| 2025-08-01 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 10.9 KB | |
| 2025-07-28 08:00 |
Earnings Release
Half Year Trading Update
|
English | 23.8 KB | |
| 2025-07-02 08:00 |
Board/Management Information
Director Declaration
|
English | 9.6 KB | |
| 2025-06-23 08:00 |
M&A Activity
OXB completes acquisition of US subsidiary
|
English | 12.3 KB | |
| 2025-06-17 19:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 18.8 KB | |
| 2025-06-11 08:02 |
Pre-Annual General Meeting Information
AGM Update
|
English | 12.6 KB | |
| 2025-06-10 11:49 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.2 KB | |
| 2025-06-05 08:00 |
Share Issue/Capital Change
Block Listing Application
|
English | 10.8 KB | |
| 2025-06-03 08:00 |
Board/Management Information
OXB Launches Advisory Board
|
English | 21.4 KB | |
| 2025-06-02 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 10.8 KB | |
| 2025-05-16 18:52 |
Director's Dealing
Grant of options
|
English | 204.1 KB |
Automate Your Workflow. Get a real-time feed of all Oxford Biomedica PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Oxford Biomedica PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
